Prosthetic Device in Children With Upper Congenital Limb Deficiency

Sponsor
Oregon Health and Science University (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT04059107
Collaborator
Limbitless Solutions (Other), University of Central Florida (Other)
20
2
1
30
10
0.3

Study Details

Study Description

Brief Summary

This is a study being performed to evaluate the safety and effectiveness of 3D printed myoelectric prosthetic devices in children with a congenital upper limb deficiency.

Condition or Disease Intervention/Treatment Phase
  • Device: 3D Printed Myoelectric Prosthetic Device
N/A

Detailed Description

The purpose of this study is to learn more about whether myoelectric prosthetic devices would be beneficial and useful for children. The study protocol specifies 4 study visits over the course of a year at the following intervals: baseline, 3 month, 6 month, 12 months. In following the protocol, each study visit will use the Assessment of Capacity for Myoelectric Control (ACMC) functional testing. The study participants will also complete several parent-child reported health related quality of life and musculoskeletal questionnaires. Specifically, the Pediatric Outcomes Data Collection Instrument (PODCI), the Pediatric Quality of Life Inventory (PedsQL), and the Children's Hand-Use Experience Questionnaire (CHEQ) will be used to measure efficacy of the myoelectric devices..

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Evaluation of 3D Printed Myoelectric Prosthetics in Children With Upper Congenital Limb Deficiency
Actual Study Start Date :
Jul 3, 2019
Anticipated Primary Completion Date :
Sep 30, 2021
Anticipated Study Completion Date :
Dec 31, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Prosthetic Device

3D Printed Myoelectric Prosthetic Device

Device: 3D Printed Myoelectric Prosthetic Device
3D Printed Myoelectric Prosthetic Device

Outcome Measures

Primary Outcome Measures

  1. Primary Safety Endpoint - Measuring safety of the device through adverse event reporting. [12 months]

    The safety of the device will be measured through parental reporting and recorded observations of adverse events.

  2. Children's experiences of using the myoelectric device while performing bi-manual tasks as assessed using a self-report questionnaire. [12 months]

    This assessment will measure the ability of the user to perform day-to-day tasks on three scales: grasp, performance time, and level of frustration.

  3. Detects expected change in a person's ability to to do various functions while performing a specific task and scoring their motions. [12 months]

    This assessment will evaluate the ability of the myoelectric device use on functions that involve griping, holding, releasing, and coordinating between limbs using the Assessment of Capacity for Myoelectric Control (ACMC).

  4. This self-report or parent-report tool is used to assess musculoskeletal health of the myoelectric device user. [12 months]

    This assessment contains six scales Upper Extremity Physical Function; Mobility/Transfers; Sports/Physical Function; Pain/Comfort; Happiness; and Global Function.

  5. A self-report and parent-report sectional approach to measuring health-related quality of life. [12 months]

    This assessment uses four generic core scales including: physical health, emotional functioning, social functioning, and school functioning.

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Years to 17 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Children between the ages of 6 to 17 with congenital/infant upper limb deficiency identified by Limbitless Solutions will be referred to OHSU for evaluation and selection.

  • All approved and consented subjects will receive a Limbitless 3D printed myoelectric device as delivered by established protocol.

  • Preference will be given to children with long term previous experience with Limbitless Solutions' bionic systems.

Exclusion Criteria:
  • Non English-speaking children and families. Due to the entirely volunteer nature of this project, the investigators are unable to hire appropriate translation services or create translated forms and surveys in other languages currently.

  • Shoulder or wrist disarticulation will be excluded.

Contacts and Locations

Locations

Site City State Country Postal Code
1 The University of Central Florida Orlando Florida United States 32816
2 Oregon Health & Science University Portland Oregon United States 97239

Sponsors and Collaborators

  • Oregon Health and Science University
  • Limbitless Solutions
  • University of Central Florida

Investigators

  • Principal Investigator: Albert Chi, MD, Oregon Health and Science University

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Albert Chi, Principal Investigator, Oregon Health and Science University
ClinicalTrials.gov Identifier:
NCT04059107
Other Study ID Numbers:
  • OHSU IRB17087
First Posted:
Aug 16, 2019
Last Update Posted:
Mar 10, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 10, 2021